ReviewInternational journal of molecular sciences2026

Targeting the Gut-Heart Axis in Diabetic Heart Failure: Microbiota and SGLT2is as Converging Therapeutic Frontiers.

Yen Chu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.